NKLR

Terra Innovatum Global N.V. (NKLR) - 10-K Summary

Business Context and Reporting Period

Company: Terra Innovatum Global N.V.
Reporting Period: Fiscal year ended December 31, 2025.
Business Model: Developer of the SOLO Micro-Modular Nuclear Reactor (MMR), a 1MWe gas-cooled reactor designed for industrial, data center, and remote applications. The company is in the pre-revenue development stage, focusing on engineering design, regulatory engagement with the U.S. Nuclear Regulatory Commission (NRC), and supply chain planning.
Recent Corporate Action: On October 9, 2025, the company consummated a business combination with GSR III Acquisition Corp. (a SPAC), becoming a publicly traded entity on Nasdaq under the symbol "NKLR". The transaction was accounted for as a recapitalization.

Key Financial Metrics

Note: All financial figures are presented in thousands of USD as per the filing, except where noted as exact amounts in the text. The 2025 Net Income is primarily driven by non-cash fair value adjustments rather than operational profitability.

Material Changes vs. Prior Period

• Profitability Shift: The company moved from a net loss of $34 in 2024 to a net income of $539,524 in 2025. This reversal is not due to revenue generation but is attributed to a $559,967 unrealized gain on the change in fair value of a share-settled contingent liability and a $16,588 gain on warrant liabilities.
• Expense Growth: Total operating expenses increased significantly from $153 in 2024 to $33,699 in 2025. This includes a rise in General and Administrative expenses (driven by share-settled contingent liabilities, professional fees, and board compensation) and Development costs (technical consultancy and salaries).
• Liquidity Event: Cash balances surged from $69 to $102,882 following the Business Combination and PIPE financing, which generated net proceeds of approximately $106,713.
• Debt Elimination: All outstanding Bridge Loans ($5,690 principal) and related party loans were converted into ordinary shares or repaid upon the closing of the Business Combination, resulting in zero debt on the balance sheet as of year-end.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management targets commercial deployment of the First-of-a-Kind (FOAK) SOLO reactor by 2028. The company expects to continue incurring losses and negative operating cash flows until commercialization is achieved.
• Unusual Items: The reported net income is heavily influenced by non-cash accounting adjustments related to the fair value of contingent liabilities and warrants. Operating cash flow remains negative ($10,297 used).
• Material Weaknesses: The company identified four material weaknesses in internal controls over financial reporting, including a lack of sufficient SOX-compliant personnel, failure to assess the impact of the de-SPAC transaction on controls, and lack of a monitoring program. Remediation is planned for 2026.
• Key Risks:
  • Regulatory: No guarantee of NRC licensing; delays could materially impact the business.
  • Commercial: No revenue to date; no binding customer agreements for SOLO deployment.
  • Capital: Substantial additional funding required; future financing may be dilutive.
  • Technology: Limited operating experience for this reactor type; supply chain scaling risks.

Investor Verification Checklist

• Revenue Reality: Verify that the company has generated zero revenue and that the reported net income is entirely non-operational (fair value adjustments).
• Cash Runway: Assess if the $102.9 million cash balance is sufficient to fund operations through the targeted 2028 commercial deployment, given the history of negative operating cash flows.
• Internal Controls: Review the remediation plan for the identified material weaknesses in internal controls, as these pose a risk to the reliability of future financial reporting.
• Regulatory Milestones: Monitor progress with the U.S. NRC, as licensing is a critical path item for any future revenue.
• Dilution Risk: Examine the terms of outstanding warrants (PIPE and Bridge) and contingent convertible preferred shares, which represent significant potential dilution to existing shareholders.